Characterization of the Effect of a Novel γ-secretase Modulator on A&bgr;: A Clinically Translatable Model

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|20|15|2484-2490

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.15, 2014-05, pp. : 2484-2490

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reduction of A&bgr; Levels in the Sprague Dawley Rat After Oral Administration of the Functional g-Secretase Inhibitor, DAPT: A Novel Non- Transgenic Model for A&bgr; Production Inhibitors

By  

Current Pharmaceutical Design, Vol. 12, Iss. 6, 2006-02 ,pp. : 671-676

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and Modulators of &bgr;- and &ggr;-Secretase

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 377-392

Bentham Science Publishers

Access to resources Recommend Favorite

The Search for &ggr;-Secretase and Development of Inhibitors

By  

Current Medicinal Chemistry, Vol. 9, Iss. 11, 2002-06 ,pp. : 1087-1106

Bentham Science Publishers

Access to resources Recommend Favorite

&ggr;-Secretase as a Target for Alzheimer's Disease

By  

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 4, 2002-04 ,pp. : 371-383

Bentham Science Publishers

Access to resources Recommend Favorite

Novel γ-secretase modulators for the treatment of Alzheimer's disease: a review focusing on patents from 2010 to 2012

By Pettersson Martin   Stepan Antonia F   Kauffman Gregory W   Johnson Douglas S  

Expert Opinion on Therapeutic Patents, Vol. 23, Iss. 10, 2013-10 ,pp. : 1349-1366

Informa Healthcare

Access to resources Recommend Favorite